Optimum preparation of levocarnitine chloride solution in the hospital pharmacy

Hiroaki Tanaka, Masato Asakura, Chiaki Doi, Noriyasu Fukuoka, Eiji Tamai, Shigeru Miyata, Osamu Matsushita, Akinobu Okabe, Kiyoshi Negayama, Hitoshi Houchi

Research output: Contribution to journalArticle

Abstract

Levocarnitine chloride is used for the therapeutic purpose of levocarnitine deficiency. For infants, however, levocarnitine chloride tablets must be crushed to avoid difficulties associated with swallowing, and also to administer an appropriately low dosage. Since the tablet is extremely hygroscopic and sour, it is dissolved in water containing simple syrup after crushing. In this study we investigated the stability of the drug after dissolution to optimize its preparation for clinical use. It was shown to be stable for at least 90 days after preparation, and microbes did not grow in 1-10% (w/v) solutions (pH 2.0-2.5) regardless of the presence or absence of simple syrup. Furthermore, the autoclaved levocarnitine chloride solution was as stable as the non-autoclaved one. In conclusion, the method employed in our hospital for the preparation of levocarnitine chloride for infants is appropriate and is recommended as a standard medicine supply method among different facilities.

Original languageEnglish
Pages (from-to)805-809
Number of pages5
JournalYakugaku Zasshi
Volume126
Issue number9
DOIs
Publication statusPublished - 2006
Externally publishedYes

Fingerprint

Carnitine
Chlorides
Tablets
Deglutition
Water

Keywords

  • Infants
  • Levocarnitine chloride
  • Levocarnitine deficiency
  • Optimum preparation
  • Preparation

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Tanaka, H., Asakura, M., Doi, C., Fukuoka, N., Tamai, E., Miyata, S., ... Houchi, H. (2006). Optimum preparation of levocarnitine chloride solution in the hospital pharmacy. Yakugaku Zasshi, 126(9), 805-809. https://doi.org/10.1248/yakushi.126.805

Optimum preparation of levocarnitine chloride solution in the hospital pharmacy. / Tanaka, Hiroaki; Asakura, Masato; Doi, Chiaki; Fukuoka, Noriyasu; Tamai, Eiji; Miyata, Shigeru; Matsushita, Osamu; Okabe, Akinobu; Negayama, Kiyoshi; Houchi, Hitoshi.

In: Yakugaku Zasshi, Vol. 126, No. 9, 2006, p. 805-809.

Research output: Contribution to journalArticle

Tanaka, H, Asakura, M, Doi, C, Fukuoka, N, Tamai, E, Miyata, S, Matsushita, O, Okabe, A, Negayama, K & Houchi, H 2006, 'Optimum preparation of levocarnitine chloride solution in the hospital pharmacy', Yakugaku Zasshi, vol. 126, no. 9, pp. 805-809. https://doi.org/10.1248/yakushi.126.805
Tanaka H, Asakura M, Doi C, Fukuoka N, Tamai E, Miyata S et al. Optimum preparation of levocarnitine chloride solution in the hospital pharmacy. Yakugaku Zasshi. 2006;126(9):805-809. https://doi.org/10.1248/yakushi.126.805
Tanaka, Hiroaki ; Asakura, Masato ; Doi, Chiaki ; Fukuoka, Noriyasu ; Tamai, Eiji ; Miyata, Shigeru ; Matsushita, Osamu ; Okabe, Akinobu ; Negayama, Kiyoshi ; Houchi, Hitoshi. / Optimum preparation of levocarnitine chloride solution in the hospital pharmacy. In: Yakugaku Zasshi. 2006 ; Vol. 126, No. 9. pp. 805-809.
@article{a21ebc124fff453ab924a56b733b4fec,
title = "Optimum preparation of levocarnitine chloride solution in the hospital pharmacy",
abstract = "Levocarnitine chloride is used for the therapeutic purpose of levocarnitine deficiency. For infants, however, levocarnitine chloride tablets must be crushed to avoid difficulties associated with swallowing, and also to administer an appropriately low dosage. Since the tablet is extremely hygroscopic and sour, it is dissolved in water containing simple syrup after crushing. In this study we investigated the stability of the drug after dissolution to optimize its preparation for clinical use. It was shown to be stable for at least 90 days after preparation, and microbes did not grow in 1-10{\%} (w/v) solutions (pH 2.0-2.5) regardless of the presence or absence of simple syrup. Furthermore, the autoclaved levocarnitine chloride solution was as stable as the non-autoclaved one. In conclusion, the method employed in our hospital for the preparation of levocarnitine chloride for infants is appropriate and is recommended as a standard medicine supply method among different facilities.",
keywords = "Infants, Levocarnitine chloride, Levocarnitine deficiency, Optimum preparation, Preparation",
author = "Hiroaki Tanaka and Masato Asakura and Chiaki Doi and Noriyasu Fukuoka and Eiji Tamai and Shigeru Miyata and Osamu Matsushita and Akinobu Okabe and Kiyoshi Negayama and Hitoshi Houchi",
year = "2006",
doi = "10.1248/yakushi.126.805",
language = "English",
volume = "126",
pages = "805--809",
journal = "Yakugaku Zasshi",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "9",

}

TY - JOUR

T1 - Optimum preparation of levocarnitine chloride solution in the hospital pharmacy

AU - Tanaka, Hiroaki

AU - Asakura, Masato

AU - Doi, Chiaki

AU - Fukuoka, Noriyasu

AU - Tamai, Eiji

AU - Miyata, Shigeru

AU - Matsushita, Osamu

AU - Okabe, Akinobu

AU - Negayama, Kiyoshi

AU - Houchi, Hitoshi

PY - 2006

Y1 - 2006

N2 - Levocarnitine chloride is used for the therapeutic purpose of levocarnitine deficiency. For infants, however, levocarnitine chloride tablets must be crushed to avoid difficulties associated with swallowing, and also to administer an appropriately low dosage. Since the tablet is extremely hygroscopic and sour, it is dissolved in water containing simple syrup after crushing. In this study we investigated the stability of the drug after dissolution to optimize its preparation for clinical use. It was shown to be stable for at least 90 days after preparation, and microbes did not grow in 1-10% (w/v) solutions (pH 2.0-2.5) regardless of the presence or absence of simple syrup. Furthermore, the autoclaved levocarnitine chloride solution was as stable as the non-autoclaved one. In conclusion, the method employed in our hospital for the preparation of levocarnitine chloride for infants is appropriate and is recommended as a standard medicine supply method among different facilities.

AB - Levocarnitine chloride is used for the therapeutic purpose of levocarnitine deficiency. For infants, however, levocarnitine chloride tablets must be crushed to avoid difficulties associated with swallowing, and also to administer an appropriately low dosage. Since the tablet is extremely hygroscopic and sour, it is dissolved in water containing simple syrup after crushing. In this study we investigated the stability of the drug after dissolution to optimize its preparation for clinical use. It was shown to be stable for at least 90 days after preparation, and microbes did not grow in 1-10% (w/v) solutions (pH 2.0-2.5) regardless of the presence or absence of simple syrup. Furthermore, the autoclaved levocarnitine chloride solution was as stable as the non-autoclaved one. In conclusion, the method employed in our hospital for the preparation of levocarnitine chloride for infants is appropriate and is recommended as a standard medicine supply method among different facilities.

KW - Infants

KW - Levocarnitine chloride

KW - Levocarnitine deficiency

KW - Optimum preparation

KW - Preparation

UR - http://www.scopus.com/inward/record.url?scp=33748494887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748494887&partnerID=8YFLogxK

U2 - 10.1248/yakushi.126.805

DO - 10.1248/yakushi.126.805

M3 - Article

C2 - 16946594

AN - SCOPUS:33748494887

VL - 126

SP - 805

EP - 809

JO - Yakugaku Zasshi

JF - Yakugaku Zasshi

SN - 0031-6903

IS - 9

ER -